Mark Goldsmith
12Patents
5h-index
28Co-inventors
66Inventor score
Filing activity: Oct 22, 1992 → Mar 5, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5861290A | Methods and polynucleotide constructs for treating host cells for infection or hyperproliferative disorders | Chemistry; Metallurgy | 41 | Expired |
| US5837510A | Methods and polynucleotide constructs for treating host cells for infection or hyperproliferative disorders | Chemistry; Metallurgy | 30 | Expired |
| US6372956B1 | Transgenic rats and rat cell lines expressing human CD4 and a human chemokine receptor | Human Necessities | 24 | Expired |
| US8522345B2 | Management of hierarchical reference data | Physics | 15 | Active |
| US7827591B2 | Management of hierarchical reference data | Physics | 6 | Expired |
| US8697169B2 | Methods and compositions for fining beverages | Chemistry; Metallurgy | 3 | Active |
| US6451598B1 | Cell fusion assays for the identification of antiviral compounds, and systems and kits for practicing the same | Physics | 3 | Expired |
| US9504678B2 | Oral dosage forms including an antiplatelet agent and an acid inhibitor | Human Necessities | 1 | Active |
| US7803555B2 | Methods and compositions for use in the treatment of filovirus mediated disease conditions | Physics | 0 | Active |
| US9532945B2 | Oral dosage forms including an antiplatelet agent and an enterically coated acid inhibitor | Human Necessities | 0 | Active |
| US6933108B2 | Methods and compositions for use in the treatment of filovirus mediated disease conditions | Physics | 0 | Expired |
| US11596633B2 | SHP2 inhibitor compositions and methods for treating cancer | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.